2020 Melanoma Treatment Updates - Dr. Roochi Arora, MD, FRCPC
Dr. Roochi Arora, MD, FRCPC, Clinical Researcher, Juravinski Cancer Centre - Presents Melanoma Treatment Updates. Discussing Adjuvant therapy ...
MelanomaCanada
Immunotherapy for metastatic RCC - EMPIRE Urology Lecture Series
Dr. A Ari Hakimi discusses Immunotherapy for metastatic renal cell carcinoma 5/28/20.
EMPIRE Urology
Lousie Perkins-Melanoma-View from the Frontlines of Immunotherapy and Precision Medicine
Melanoma arises in the pigment producing cells (melanocytes) and is the deadliest of the skin cancers. It accounts for nearly 200000 new cases of cancer each ...
LabRoots
Dr. Saenger on Immunotherapy Combinations in Melanoma
Yvonne Saenger, MD, director of Melanoma Immunotherapy at Columbia University Medical Center, discusses immunotherapy combinations in melanoma.
OncLiveTV
Symposium 10: Structure and function of cytokines
Presented By: Speaker Biography: Webinar: Symposium 10: Structure and function of cytokines Webinar Abstract:
LabRoots
Surgery, isolated limb perfusion, injectable therapy or systemic therapy for in-transit melanoma
Drs. John M. Kirkwood and Antoni Ribas chaired the Perspectives in Melanoma XVII meeting on September 13-14, 2013 in Baltimore, Maryland. This webcast is ...
ImedexCME
Results of KEYNOTE-054; melanoma patients treated with pembrolizumab
Prof Eggermont presents results at AACR 2018 from KEYNOTE-054, assessing disease recurrence rates in melanoma patients treated with pembrolizumab.
ecancer
Ocular and Mucosal Melanoma: New Directions
Presentation given by Richard D. Carvajal, MD, as part of the "Melanoma and Skin Cancer Patient and Caregiver Symposium" sponsored by AIM at Melanoma ...
AIMatMelanoma
New Developments In the Treatment of Advanced Melanoma
Patient and Caregiver Symposium held in Los Angeles, California at University of California, Los Angeles in which leading melanoma expert Dr. Antoni Ribas ...
AIMatMelanoma
Study Details First Therapeutic Melanoma Vaccine
Download from iTunes: http://itunes.apple.com/us/podcast/study-details-first-therapeutic/id431848216?i=94640693 Scientists, led by Patrick Hwu, M.D., of MD ...
MD Anderson Cancer Center
Update on oncolytic virus therapy for melanoma
Drs. John M. Kirkwood and Antoni Ribas chaired the Perspectives in Melanoma XVII meeting on September 13-14, 2013 in Baltimore, Maryland. This webcast is ...
ImedexCME
Ocular Melanoma: Innovative Treatments and Beyond
Dr. Marcus Butler, of Princess Margaret Cancer Centre, Toronto, Ontario, Canada and Dr. Omid Hamid, of The Angeles Clinic and Research Institute, Los ...
saveyourskinfdn
Dr. Luke on the FDA Approval of Adjuvant Nivolumab in Melanoma
Jason J. Luke, MD, assistant professor of medicine, University of Chicago Medicine, discusses the FDA approval of nivolumab (Opdivo) to treat patients with ...
OncLiveTV
Do I Need More Treatment After Surgery?
This presentation is given by Juraj Kavecansky, MD, Medical Oncology at Kaiser Permanente Antioch Medical Center. The presentation is part of AIM at ...
AIMatMelanoma
Novel strategy could help overcome resistance to radiotherapy in metastatic melanoma
Dr Dutreix talks to ecancertv about the results of the first-in-human trial of the DNA repair inhibitor DT01 in combination with radiotherapy show promising results ...
ecancer
Vaccines for the treatment and prevention of cancer
Presented By: Keith Knutson, PhD Speaker Biography: Keith L. Knutson, Ph.D., is a consultant in the Department of Immunology, Mayo Clinic in Florida, where ...
LabRoots
Systemic Therapy for Advanced Melanoma
Ahmad Tarhini, MD, PhD, talks about systemic therapy for advanced melanoma. The presentation is part of the AIM at Melanoma's Patient & Caregiver ...
AIMatMelanoma
Adjuvant Therapy for Melanoma: Do I Need It?
Thach-Giao Truong, MD, Melanoma Program Lead at Kaiser Permanente Northern California. The presentation is part of AIM at Melanoma's Living with ...
AIMatMelanoma
Immunoregulation and T cell Tolerance with Arlene Sharpe, MD, PhD
Dr. Arlene Sharpe presents on immunoregulation and t cell tolerance. This video was recorded on May 18, 2019 at the Annual Advances in Cancer ...
MGHCancerCenter
MELANOMA CUTANEO
MELANOMA CUTANEO DRA. JAZMIN AIDEE GOMÉZ SMEO 20191009 MELANOMACUTANEO DRAYAZMINAIDEEGÓMEZ.
SMeO Sociedad Mexicana de Oncología
Updates in Medical Management of Melanoma
Presentation given by Kenneth Grossman, MD as part of the AIM at Melanoma's Patient & Caregiver Symposium on February 6, 2016 at the OSUCCC - James in ...
AIMatMelanoma
Zoeken naar clinical trials of experimentele behandeling voor melanoom
Deze video kunt u het beste op 720p HD kwaliteit bekijken. Bij stichting melanoom komen veel vragen binnen over het zoeken naar de meest recente trails.
StichtingMelanoom
Combination Immunotherapy with Vaccines - Bernard A. Fox, Ph.D.
Seattle Science Foundation is a non-profit organization dedicated to the international collaboration among physicians, scientists, technologists, engineers and ...
Seattle Science Foundation
2018 Congress Archived Session: Evolving Strategies for Immunotherapy Side-Effect Management
Program Overview: Immunotherapies are becoming widely used in cancer care. With administration of these medications come immune-related adverse events.
Oncology Nursing Society
Bevacizumab and Interferon in mRCC
Nizar M. Tannir, MD, FACP, comments on the appropriateness for bevacizumab and interferon as combination therapy in patients with newly diagnosed ...
OncLiveTV
COVID-19: Enrichment and analysis of rare antigen- and virus-specific T cells [WEBINAR]
Miltenyi Biotec's enrichment and analysis solutions are perfectly suited for the examination of rare antigen- and virus-specific T cells and will assist you in even ...
Miltenyi Biotec
Louise Perkins - A Case Study for Immunotherapies and Targeted Therapies
Watch on LabRoots at http://labroots.com/webcast/id/584 Melanoma, a cancer of pigment-producing cells, accounts for nearly 200000 new cases of cancer ...
LabRoots
Developments in melanoma – new treatment options
Dirk Schadendorf, MD, PhD, from the University Hospital Essen, Essen, Germany, discusses developments in melanoma treatment at the European Cancer ...
VJOncology
Hairy cell leukemia: New targets, new therapy
This outstanding webcast of Lymphoma & Myeloma 2013, an International Congress on Hematologic Malignancies, includes experts presenting the current ...
ImedexCME
"What is life - lecture" Dirk Jäger
Title: Howe to individualise cancer treatment Dirk Jäger, Professor, Clinical Leader, NCT (Nationales Centrum Für Tumorerkrankung) DKFZ and University ...
Karolinska Institutet
Adil Daud - Recent Developments in the treatment of Melanoma
Watch on LabRoots at: http://labroots.com/user/webinars/details/id/124 While Melanoma is very curable and treatable when detected early, late stage melanoma ...
LabRoots
Deciphering Immuno-oncology: Targeting Innate Immunity in Cancer
While targeting T cells has proven to be a technically successful treatment protocol for most cancer immunotherapies, only a fraction of cancer patients respond ...
Cell Signaling Technology, Inc.
Remodeling the Tumor Environment to Improve Immunotherapy Outcomes
Yana Najjar, MD, Assistant Professor of Medicine at UPMC Hillman Cancer Center presents as of part of AIM's Living With Melanoma Symposium co-hosted with ...
AIMatMelanoma
Immunotherapy of Melanoma Targeting PD-1 and Other Inhibitory Receptors
Hassane Zarour, MD, talks about immunotherapy of Mmelanoma targeting PD-1 and other inhibitory receptors The presentation is part of the AIM at Melanoma's ...
AIMatMelanoma
Keynote - Cancer Immunology (Carl H. June)
Introduction: Steven J. Burakoff, Dean for Cancer Innovation; Lillian and Henry M. Stratton Professor of Cancer Medicine, Icahn School of Medicine at Mount ...
Icahn School of Medicine
Yale Cancer Center Grand Rounds | December 8, 2020
"Type I Interferon Transcriptional Network Regulates Expression of Co-inhibitory Receptors on Human T cells" and "co-Stimulating Innate and Adaptive Immunity ...
Yale Cancer Center
Melanoma vaccines - video abstract 32396
Video abstract of review paper "Melanoma vaccines: trials and tribulations" published in the open access journal Vaccine: Development and Therapy by author ...
Dove Medical Press
Investigation of NK cell-driven tumor immunity using novel image cytometry detection method
Presented By: Lucas Ferrari de Andrade, Ph.D. Leo Chan, Ph.D. Speaker Biography: Lucas Ferrari de Andrade, Ph.D. Lucas received in 2014 his PhD in ...
LabRoots
Melanoma Update Presentation, Part 2 Natalie Mandolfo
IowaWestern
Treating Bladder Cancer 1 - Non Muscle Invasive Bladder Cancer
This webinar covers treatment options for non-muscle invasive bladder cancer such as transurethral resection of a bladder tumor (TURBT), Mitomycin C, ...
Bladder Cancer Advocacy Network
The importance of liquid biopsy MSI for studying tumors and immunotherapy applications...
Presented By: Paul R. Walker, MD, FACP Speaker Biography: Dr. Paul Walker is a graduate of the Indiana University School of Medicine and Associate ...
LabRoots
Glyco-checkpoints as Therapeutic Targets in Cancer, Autoimmunity & Infection by Dr. G. Rabinovich
GLOBAL IMMUNOTALK 11-11-2020.
GLOBAL IMMUNOTALKS
